These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 29606187

  • 1. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC.
    Biomed Environ Sci; 2018 Feb; 31(2):87-96. PubMed ID: 29606187
    [Abstract] [Full Text] [Related]

  • 2. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H, Li J, Huang L, Chen X, Li D, Wang T, Hu C, Xu J, Zhang C, Zen K, Xiao S, Yan Q, Wang C, Zhang CY.
    Dis Markers; 2015 Feb; 2015():625659. PubMed ID: 26078483
    [Abstract] [Full Text] [Related]

  • 3. ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease.
    Liu CG, Zhao Y, Lu Y, Wang PC.
    Biomed Res Int; 2021 Feb; 2021():5450397. PubMed ID: 33763470
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-135a in ABCA1-labeled Exosome is a Serum Biomarker Candidate for Alzheimer's Disease.
    Liu CG, Meng S, Li Y, Lu Y, Zhao Y, Wang PC.
    Biomed Environ Sci; 2021 Jan 20; 34(1):19-28. PubMed ID: 33531104
    [Abstract] [Full Text] [Related]

  • 5. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C, Mostile G, Baglieri G, Giunta F, Luca A, Raciti L, Zappia M, Purrello M, Ragusa M, Nicoletti A.
    Cell Mol Neurobiol; 2020 May 20; 40(4):531-546. PubMed ID: 31691877
    [Abstract] [Full Text] [Related]

  • 6. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L, Zhao Y, Lu Z.
    J Alzheimers Dis; 2017 May 20; 60(4):1365-1377. PubMed ID: 29036818
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease.
    Liu CG, Song J, Zhang YQ, Wang PC.
    Mol Med Rep; 2014 Nov 20; 10(5):2395-400. PubMed ID: 25119742
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment.
    Xie B, Zhou H, Zhang R, Song M, Yu L, Wang L, Liu Z, Zhang Q, Cui D, Wang X, Xu S.
    J Alzheimers Dis; 2015 Nov 20; 45(3):721-31. PubMed ID: 25589731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F, Liu X, Li F, Liu H, Sun L, Zhao K.
    Mol Neurobiol; 2021 Jul 20; 58(7):3084-3094. PubMed ID: 33629272
    [Abstract] [Full Text] [Related]

  • 12. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J, Chen C, Zhang Y.
    J Clin Lab Anal; 2020 Jan 20; 34(1):e23006. PubMed ID: 31420923
    [Abstract] [Full Text] [Related]

  • 13. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N, Kikuchi M, Miyashita A, Hatsuta H, Saito Y, Kasuga K, Murayama S, Ikeuchi T, Kuwano R.
    Acta Neuropathol Commun; 2017 Jan 31; 5(1):10. PubMed ID: 28137310
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline.
    Li Y, Xia M, Meng S, Wu D, Ling S, Chen X, Liu C.
    Neurobiol Dis; 2022 Sep 31; 171():105800. PubMed ID: 35752392
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Sep 31; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 16. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T, Tan L.
    J Neurol Sci; 2014 Jan 15; 336(1-2):52-6. PubMed ID: 24139697
    [Abstract] [Full Text] [Related]

  • 17. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
    Siedlecki-Wullich D, Català-Solsona J, Fábregas C, Hernández I, Clarimon J, Lleó A, Boada M, Saura CA, Rodríguez-Álvarez J, Miñano-Molina AJ.
    Alzheimers Res Ther; 2019 May 15; 11(1):46. PubMed ID: 31092279
    [Abstract] [Full Text] [Related]

  • 18. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY, Modi M, Garg VK, Mohanty M, Goyal MK, Lal V, Mittal BR, Prabhakar S.
    Asian J Psychiatr; 2017 Oct 15; 29():59-62. PubMed ID: 29061429
    [Abstract] [Full Text] [Related]

  • 19. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T, Tan L.
    J Alzheimers Dis; 2014 Oct 15; 40(4):1017-27. PubMed ID: 24577456
    [Abstract] [Full Text] [Related]

  • 20. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B, Liu Z, Jiang L, Liu W, Song M, Zhang Q, Zhang R, Cui D, Wang X, Xu S.
    J Alzheimers Dis; 2017 Oct 15; 55(2):509-520. PubMed ID: 27662297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.